CAPTRUST FINANCIAL ADVISORS - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,000
-33.3%
502
-43.3%
0.00%
Q1 2022$6,000
-14.3%
885
+7.5%
0.00%
Q4 2021$7,000
+600.0%
823
+3065.4%
0.00%
Q2 2021$1,00026
+550.0%
0.00%
Q1 2021$040.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$22,222,0001.76%
EcoR1 Capital, LLC 5,376,134$48,063,0001.53%
Cormorant Asset Management, LP 1,679,442$15,014,0000.89%
CM Management, LLC 100,000$894,0000.68%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 596,800$5,335,0000.40%
PDT Partners, LLC 278,487$2,490,0000.19%
Ikarian Capital, LLC 116,600$1,043,0000.16%
HighVista Strategies LLC 20,659$185,0000.15%
Aristides Capital LLC 35,132$314,0000.14%
Parkwood LLC 71,932$643,0000.11%
View complete list of ATEA PHARMACEUTICALS INC shareholders